Brief: Everest Medicines Says Kerry Levan Blanchard Resigned As Chief Executive Officer
26/08/2022 02:15
Aug 26 (Reuters) - Everest Medicines Ltd 1952.HK :
* KERRY LEVAN BLANCHARD RESIGNED AS AN EXECUTIVE DIRECTOR
AND
CHIEF EXECUTIVE OFFICER
* IAN YING WOO WILL ASSUME INTERIM DUTIES OF CHIEF EXECUTIVE
OFFICER UNTIL A NEW CHIEF EXECUTIVE OFFICER IS APPOINTED
Further company coverage: 1952.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region